Enterprise List
The company was jointly invested and established with a capital of 150 million yuan by Xinghu Technology, a subsidiary of Guangxin Holding Group, and Guangdong Guangxin Innovation Research Institute Co., Ltd. It serves as the R&D headquarters for Xinghu Technology and its subsidiary Yipin Biology. On May 23, 2024, the company, along with the Xinghu Yipin Central Research Institute, officially commenced operations at the Yinxing Synthetic Biology Industrial Park in Guangming District, Shenzhen.
Relying on its self-developed key reagents, consumables, and synthetic equipment, it provides efficient, high-quality, and personalized gene synthesis/detection services and related products for basic science and cutting-edge technology research. QinKe Biotech advocates and implements the concept of building a gene factory, which supports the research and industrialization in various fields such as biomedicine, biomanufacturing, agriculture, food, and the environment from the ground up.
Shenzhen Saiqiao Biological Innovation Technology Co., Ltd. was established in March 2020, co-founded by Professor Zhang Youming, a PhD from the Department of Precision Instrumentation at Tsinghua University and a foreign academician of the Chinese Academy of Engineering. The core team has been responsible for major national biological instrument projects and possesses over 10 years of experience in instrument engineering and biotechnology. It is the earliest professional team in China to specialize in cell processing and automation equipment
Founded in 2022, Shenzhen Termi Technology Co., Ltd. takes unique bioorthogonal (& click chemistry) and biochemical technology as the core and foundation, and relies on four major technology platforms of protein engineering, chemical synthesis, separation and purification, analysis and detection to support the development of underlying tools and raw materials for synthetic biology. The company is committed to providing life science reagents, consumables, instruments and CRO and CDMO services for enterprises and biotechnology innovators
Jotbody (HK) Limited, established in 2020, is a company dedicated to nanobody research and global cell movement R&D. We specialize in nanobody discovery technology and possess extensive experience in customizing camel VHH and shark vNAR. We offer comprehensive services in the field of nanobody research and development, encompassing antigen design and preparation, humanization and affinity maturation of nanobodies, protein expression, and coupling modification services.
